Ghrelin Mimetics: How GHRP Peptides Stimulate Growth Hormone

Ghrelin is the hunger hormone—a 28-amino-acid peptide produced primarily in the stomach that signals the brain to stimulate appetite and growth hormone release. Its discovery in 1999 revealed an entirely new axis for GH regulation and opened the door to a class of synthetic compounds called ghrelin mimetics or growth hormone releasing peptides (GHRPs). These synthetic analogs activate the ghrelin receptor (GHSR-1a) to stimulate GH release without ghrelin's rapid degradation and without causing hunger at the doses used for GH purposes.

The Ghrelin Receptor and GH Release

The ghrelin receptor (GHSR-1a) is expressed in the pituitary gland, hypothalamus, and peripheral tissues including the heart and GI tract. When activated in the pituitary, it triggers GH release directly. When activated in the hypothalamus, it suppresses somatostatin (the GH-inhibiting hormone) while simultaneously stimulating GHRH release—a double mechanism that amplifies GH output.

This is why combining a GHRP with a GHRH analog (like CJC-1295) produces synergistic effects rather than additive ones. The GHRH analog increases the amplitude of GH pulses while the GHRP both adds to pulse amplitude and removes the somatostatin brake. Studies show 2-3x greater GH output from the combination versus either alone.

GHRP-2: The Potent Option with Moderate Side Effects

GHRP-2 is a synthetic hexapeptide with high ghrelin receptor affinity. It produces robust GH release—among the highest of any GHRP—with moderate cortisol and prolactin elevation and mild appetite stimulation. In clinical research, GHRP-2 normalized GH levels in GH-deficient adults and improved lean body mass over 6-month protocols.

Dosing: 100-200 mcg subcutaneously 2-3x daily. It pairs well with CJC-1295 without DAC for a powerful GH pulse combination. Cycle 4-8 weeks with 2-4 week breaks due to moderate desensitization.

GHRP-6: The Hunger Peptide

GHRP-6 is the oldest of the synthetic GHRPs and has extensive research behind it. Its signature characteristic is potent appetite stimulation—GHSR-1a activation in the hypothalamus triggers hunger signals that can dramatically increase food intake within 20-30 minutes of injection. This makes GHRP-6 a deliberate tool for individuals struggling to eat enough during aggressive bulk phases.

GH output is comparable to GHRP-2. Cortisol and prolactin elevations are similar. The appetite effect is distinct and predictable. Dose: 100-200 mcg per injection. For those not seeking appetite stimulation, Ipamorelin is strictly preferable.

Ipamorelin: The Selective Ghrelin Mimetic

Ipamorelin was developed specifically to isolate the GH-releasing function of ghrelin receptor activation while minimizing the off-target effects. It achieves this through higher receptor selectivity—it activates GHSR-1a to stimulate GH without meaningfully activating the pathways responsible for cortisol or prolactin elevation at standard doses.

In head-to-head comparisons, Ipamorelin produces GH peaks roughly equivalent to GHRP-6 without the appetite stimulation, lower cortisol elevation, and negligible prolactin increase. Its side effect profile makes it the preferred GHRP for long-term health and anti-aging protocols. Dosing: 100-300 mcg per injection, up to 3x daily.

Hexarelin: Maximum Potency

As covered in the dedicated hexarelin guide, it produces the largest GH peaks of any GHRP class compound—approximately 2-3x greater GH release than Ipamorelin at equivalent doses. This comes at the cost of faster desensitization, cortisol elevation, and prolactin increase. It also has unique direct cardiac receptor activity. Best used in defined cycles rather than continuously.

MK-677 (Ibutamoren): The Oral Ghrelin Mimetic

MK-677 is a non-peptide oral ghrelin mimetic—a small molecule that activates GHSR-1a and can be taken as a pill. It produces sustained GH elevation rather than discrete pulses, resulting in 24-hour IGF-1 elevation. This continuous elevation is effective for body composition but carries a different risk profile: sustained IGF-1 elevation, water retention, and increased appetite.

Dose: 10-25 mg/day orally. Because it is orally bioavailable, it is extremely convenient but less physiological in its GH stimulation pattern. Blood glucose monitoring is recommended with chronic use.

Choosing the Right Ghrelin Mimetic

• Long-term health and anti-aging: Ipamorelin
• Maximum GH output for defined cycles: Hexarelin or GHRP-2
• Bulking with appetite enhancement: GHRP-6
• Oral convenience, ongoing GH support: MK-677
• Clinical safety data and physician oversight: Sermorelin or Tesamorelin (GHRH analogs used alone)

FAQ

Do ghrelin mimetics work in older individuals whose pituitary is less responsive? Yes, but GH output is typically lower in older individuals regardless of GHRP use because pituitary GH-producing cells (somatotrophs) decline with age. Combining with GHRH analogs helps maximize the response in older populations. Tesamorelin and Sermorelin have demonstrated efficacy specifically in older adults in clinical settings.

Can ghrelin mimetics affect gut motility? Ghrelin receptors are expressed throughout the GI tract and ghrelin is a prokinetic agent—it accelerates gut motility. GHRP peptides can share this property to varying degrees, which is part of why BPC-157 and GHRP combinations are sometimes used in GI recovery contexts.

How quickly do ghrelin mimetics begin working? GH peaks are measurable within 15-30 minutes of subcutaneous injection. IGF-1 elevation occurs over 12-24 hours as the liver responds to the GH signal. Subjective effects—deeper sleep, improved recovery—typically become noticeable within 1-2 weeks of consistent use.

Related Articles

• GHRP-2: High-Potency GH Secretagogue Explained
• GHRP-6: Growth Hormone Releasing Peptide Guide
• Afamelanotide: FDA-Approved Melanocyte Peptide
• AOD-9604: HGH Fragment for Fat Loss
• Argireline: The Topical Peptide Alternative to Botox?

Track your supplements in Optimize.